AI Summary
This article explores the kinetic properties of Glutamate Carboxypeptidase II that has been partially purified from the serum of patients with leukodystrophy. The study aims to investigate the enzyme's activity and potential implications for the disease. By understanding the kinetic properties of this enzyme, researchers hope to gain insights into the underlying mechanisms of leukodystrophy and potentially identify new therapeutic targets.